SK Biopharmaceuticals Statistics

Total Valuation

KRX:326030 has a market cap or net worth of KRW 8.06 trillion. The enterprise value is 7.87 trillion.

Market Cap	8.06T
Enterprise Value	7.87T

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:326030 has 78.31 million shares outstanding.

Current Share Class	78.31M
Shares Outstanding	78.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	13.64%
Float	28.05M

Valuation Ratios

The trailing PE ratio is 25.15 and the forward PE ratio is 30.48. KRX:326030's PEG ratio is 3.35.

PE Ratio	25.15
Forward PE	30.48
PS Ratio	11.93
PB Ratio	11.69
P/TBV Ratio	12.12
P/FCF Ratio	56.33
P/OCF Ratio	55.13
PEG Ratio	3.35

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 44.83, with an EV/FCF ratio of 55.00.

EV / Earnings	24.55
EV / Sales	11.65
EV / EBITDA	44.83
EV / EBIT	49.78
EV / FCF	55.00

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.07.

Current Ratio	2.43
Quick Ratio	1.84
Debt / Equity	0.07
Debt / EBITDA	0.23
Debt / FCF	0.35
Interest Coverage	21.99

Financial Efficiency

Return on equity (ROE) is 58.15% and return on invested capital (ROIC) is 41.79%.

Return on Equity (ROE)	58.15%
Return on Assets (ROA)	13.73%
Return on Invested Capital (ROIC)	41.79%
Return on Capital Employed (ROCE)	25.91%
Weighted Average Cost of Capital (WACC)	8.45%
Revenue Per Employee	2.75B
Profits Per Employee	1.30B
Employee Count	246
Asset Turnover	0.75
Inventory Turnover	0.31

Taxes

Income Tax	-158.26B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.58% in the last 52 weeks. The beta is 0.76, so KRX:326030's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-9.58%
50-Day Moving Average	118,138.00
200-Day Moving Average	109,092.50
Relative Strength Index (RSI)	38.74
Average Volume (20 Days)	281,337

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:326030 had revenue of KRW 675.41 billion and earned 320.47 billion in profits. Earnings per share was 4,092.19.

Revenue	675.41B
Gross Profit	641.58B
Operating Income	198.31B
Pretax Income	148.67B
Net Income	320.47B
EBITDA	215.77B
EBIT	198.31B
Earnings Per Share (EPS)	4,092.19

Full Income Statement

Balance Sheet

The company has 256.16 billion in cash and 49.37 billion in debt, giving a net cash position of 206.79 billion or 2,640.59 per share.

Cash & Cash Equivalents	256.16B
Total Debt	49.37B
Net Cash	206.79B
Net Cash Per Share	2,640.59
Equity (Book Value)	689.46B
Book Value Per Share	8,591.11
Working Capital	378.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 146.18 billion and capital expenditures -3.13 billion, giving a free cash flow of 143.05 billion.

Operating Cash Flow	146.18B
Capital Expenditures	-3.13B
Free Cash Flow	143.05B
FCF Per Share	1,826.65

Full Cash Flow Statement

Margins

Gross margin is 94.99%, with operating and profit margins of 29.36% and 47.45%.

Gross Margin	94.99%
Operating Margin	29.36%
Pretax Margin	22.01%
Profit Margin	47.45%
EBITDA Margin	31.95%
EBIT Margin	29.36%
FCF Margin	21.18%

Dividends & Yields

KRX:326030 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.98%
FCF Yield	1.78%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:326030 has an Altman Z-Score of 15.51 and a Piotroski F-Score of 6.

Altman Z-Score	15.51
Piotroski F-Score	6